NIH Wants to Tell Clinical Trial Guinea Pigs the Results
Published Date: 9/25/2026
Notice
Summary
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
Analyzed Economic Effects
5 provisions identified: 4 benefits, 1 costs, 0 mixed.
Mandatory plain‑language results for participants
If a study is supported in whole or in part by NIH, researchers and institutions must responsibly share summary level study results in plain language with clinical research participants, unless sharing is justifiably not appropriate and an exception is approved. This requirement applies to all NIH‑supported clinical research, including intramural studies.
Deadlines for sharing study summaries
For NIH‑supported clinical trials, summary level study results must be shared no later than one year after the study's primary completion date or by the date results must be reported in ClinicalTrials.gov under NIH policy, whichever is later. For extramural clinical research that is not a clinical trial, summaries must be shared no later than the end of the period of performance if analyses are complete, or a status update must be provided. For all intramural clinical research, annual status updates to participants are required beginning no later than six months after the policy effective date.
Funding consequences for noncompliance
All recipients of NIH support for clinical research must comply with the Policy; failure to comply may lead to enforcement actions such as additional special terms and conditions, termination, or other actions that may affect future NIH funding decisions for the recipient institution, consistent with applicable grant regulations and procedures.
Participants must be offered results option
Researchers must ensure that research participants are offered summary level study results, whether or not participants ultimately receive those results. If sharing will not occur, researchers should request an exception (generally before enrollment) and if sharing becomes impossible must inform participants why sharing is no longer possible.
NIH may provide supplemental guidance and support
NIH is considering issuing supplemental guidance and resources to help researchers share summary level study results in plain language, and is seeking input on the types of activities and anticipated costs needed to implement this requirement for different kinds of studies.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
Next: 2026-19707, Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request
The Centers for Medicare & Medicaid Services (CMS) wants your thoughts on their plan to keep collecting simple, low-burden info about Medicaid and CHIP programs. This helps them improve how they manage state plans, waivers, and reports without causing extra hassle. If you have ideas or concerns, speak up by October 9, 2026—your input can shape smoother healthcare paperwork!